Linear provides the most comprehensive clinical trial site capability in Australia, delivered across three specialist facilities, including the state of the art Joondalup Early Phase Centre and Australia’s first private hospital dedicated to cancer and other therapeutic trials, the Advanced Clinical Trial Centre.

Leveraging Australia’s rapid trial start-up environment and technology investments including eSource, Linear can deliver rapid trials across all phases in healthy volunteers and patient groups, including next generation molecules (RNA, bi/trispecifics and cell therapy).

As a for-purpose company and subsidiary of the Harry Perkins Institute of Medical Research, Linear is solely invested in the success of your clinical program. Our strategic colocation with multiple tertiary hospitals and research institutions guarantees that we possess the essential capabilities required for your specific needs.

Having delivered over 400 trials since opening in 2010, Linear has developed a range of innovative practices across volunteer recruitment, data capture, quality assurance and medical governance. This includes holding dedicated Medical Directors across phase I (HV), Oncology and Haematology portfolios with a deep comprehension of the regulatory landscape in Australia, enabling Linear to provide critical protocol and design optimisation, eligibility criteria review, and other key medical recommendations.

Please reach out to learn more about Linear and the Australian clinical trial sector, which offers a fast regulatory framework to move into human trials without requiring an investigational new drug application, as well as a generous R&D incentive of 43.5% cashback for pre-revenue biotech.